MetLife Investment Management’s Chemed CHE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.65M | Buy |
7,020
+43
| +0.6% | +$18.4K | 0.01% | 912 |
|
|
2025
Q4 | $2.99M | Sell |
6,977
-570
| -8% | -$248K | 0.01% | 866 |
|
|
2025
Q3 | $3.38M | Sell |
7,547
-386
| -5% | -$175K | 0.02% | 824 |
|
|
2025
Q2 | $3.86M | Sell |
7,933
-447
| -5% | -$255K | 0.02% | 686 |
|
|
2025
Q1 | $5.16M | Sell |
8,380
-131
| -2% | -$74.5K | 0.03% | 598 |
|
|
2024
Q4 | $4.51M | Buy |
8,511
+666
| +8% | +$375K | 0.02% | 617 |
|
|
2024
Q3 | $4.71M | Sell |
7,845
-193
| -2% | -$109K | 0.03% | 561 |
|
|
2024
Q2 | $4.36M | Sell |
8,038
-664
| -8% | -$380K | 0.03% | 568 |
|
|
2024
Q1 | $5.59M | Sell |
8,702
-218
| -2% | -$132K | 0.04% | 426 |
|
|
2023
Q4 | $5.22M | Sell |
8,920
-150
| -2% | -$83.9K | 0.04% | 428 |
|
|
2023
Q3 | $4.71M | Sell |
9,070
-363
| -4% | -$189K | 0.04% | 436 |
|
|
2023
Q2 | $5.11M | Buy |
9,433
+111
| +1% | +$60.7K | 0.04% | 426 |
|
|
2023
Q1 | $5.01M | Sell |
9,322
-244
| -3% | -$124K | 0.04% | 441 |
|
|
2022
Q4 | $4.88M | Sell |
9,566
-218
| -2% | -$106K | 0.04% | 449 |
|
|
2022
Q3 | $4.27M | Sell |
9,784
-158
| -2% | -$76K | 0.04% | 488 |
|
|
2022
Q2 | $4.67M | Sell |
9,942
-187
| -2% | -$91.2K | 0.04% | 462 |
|
|
2022
Q1 | $5.13M | Buy |
10,129
+2,668
| +36% | +$1.28M | 0.03% | 506 |
|
|
2021
Q4 | $3.95M | Sell |
7,461
-97
| -1% | -$46.6K | 0.03% | 523 |
|
|
2021
Q3 | $3.52M | Sell |
7,558
-412
| -5% | -$194K | 0.03% | 556 |
|
|
2021
Q2 | $3.78M | Sell |
7,970
-312
| -4% | -$150K | 0.03% | 541 |
|
|
2021
Q1 | $3.81M | Sell |
8,282
-448
| -5% | -$220K | 0.03% | 536 |
|
|
2020
Q4 | $4.65M | Sell |
8,730
-385
| -4% | -$189K | 0.04% | 384 |
|
|
2020
Q3 | $4.38M | Sell |
9,115
-312
| -3% | -$153K | 0.05% | 359 |
|
|
2020
Q2 | $4.25M | Buy |
9,427
+237
| +3% | +$106K | 0.05% | 361 |
|
|
2020
Q1 | $3.98M | Hold |
9,190
| – | – | 0.05% | 324 |
|
|
2019
Q4 | $4.04M | Sell |
9,190
-71
| -0.8% | -$29.9K | 0.04% | 459 |
|
|
2019
Q3 | $3.87M | Sell |
9,261
-183
| -2% | -$74.7K | 0.04% | 459 |
|
|
2019
Q2 | $3.41M | Sell |
9,444
-290
| -3% | -$96.9K | 0.04% | 541 |
|
|
2019
Q1 | $3.12M | Sell |
9,734
-29
| -0.3% | -$8.91K | 0.03% | 596 |
|
|
2018
Q4 | $2.77M | Sell |
9,763
-87
| -0.9% | -$26.3K | 0.03% | 597 |
|
|
2018
Q3 | $3.15M | Sell |
9,850
-167
| -2% | -$53.2K | 0.03% | 638 |
|
|
2018
Q2 | $3.22M | Buy |
10,017
+2,864
| +40% | +$896K | 0.04% | 558 |
|
|
2018
Q1 | $1.95M | Hold |
7,153
| – | – | 0.02% | 785 |
|
|
2017
Q4 | $1.74M | Buy |
+7,153
| New | +$1.62M | 0.02% | 834 |
|
Other funds holding CHE
VPM
VCM
MetLife Investment Management's CHE Position: Q1 2026 in Review
MetLife Investment Management increased its Chemed (CHE) stake by 0.62% in Q1 2026, buying an estimated $18.4K and bringing the position to 7,020 shares worth $2.65M. The position accounts for 0.01% of the portfolio, ranked #912.
MetLife Investment Management first reported a position in CHE in Q4 2017 and has held it in 34 quarters since. The position peaked at $5.59M in Q1 2024. 489 funds tracked by Wall St. Rank hold CHE as of Q1 2026.
- MetLife Investment Management held 7,020 shares of Chemed worth $2.65M as of Q1 2026.
- MetLife Investment Management bought 43 Chemed shares in Q1 2026, an estimated $18.4K.
- Chemed made up 0.01% of MetLife Investment Management's portfolio in Q1 2026, its #912 holding.
- MetLife Investment Management first reported a position in Chemed in Q4 2017 and has held it in 34 quarters since.
- MetLife Investment Management's Chemed position peaked at $5.59M in Q1 2024.
- 489 funds tracked by Wall St. Rank held Chemed as of Q1 2026.
Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.